Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes
NCT03426085Phase 2Unknown
- Sponsor
- Eastern Virginia Medical School
- Start
- May 2016
- Primary completion
- Apr 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of liraglutide in type 2 diabetes mellitus (T2DM), diabetic neuropathy, sponsored by Eastern Virginia Medical School. Status: unknown.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)diabetic neuropathy
Beyond the preview
Go deeper on NCT03426085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03426085.